Rivastigmine 13.3 mg Patch for Alzheimer's and Parkinson's - 30 Pack

USAMP#85028884SKU: 00378907293
rxLicense

License Required

wishlistAltwishlistAlt
Rivastigmine 13.3 mg Patch - Alzheimer's & Parkinson's Treatment

Product Spotlight

  • Each transdermal Rivastigmine patch is designed for continuous release, ensuring steady medication levels.
  • Formulated as a Parasympathomimetic agent, Rivastigmine aids in improving cognitive function in Alzheimer's and Parkinson's disease patients.
  • The 13.3 mg dosage strength provides effective management of neurological symptoms.
  • Manufactured by Mylan Pharmaceuticals, ensuring high-quality and consistency.
  • Packaged in a protective square pouch, each patch features a clear to slightly hazy oversized underlay for easy application and comfort.

More Information

SDS